Comparative effectiveness of treatment options for pediatric craniopharyngiomas

J Neurosurg Pediatr. 2014 Feb;13(2):178-88. doi: 10.3171/2013.11.PEDS1320. Epub 2013 Dec 6.

Abstract

Object: No clear treatment guidelines for pediatric craniopharyngiomas exist. The authors developed a decision analytical model to evaluate outcomes of 4 surgical approaches for craniopharyngiomas in children, including attempted gross-total resection (GTR), planned subtotal removal plus radiotherapy, biopsy plus radiotherapy, and endoscopic resections of all kinds.

Methods: Pooled data, including the authors' own experience, were used to create evidence tables, from which incidence, relative risks, and summary outcomes in quality-adjusted life years (QALYs) were calculated for the 4 management strategies.

Results: Quality-adjusted life years at the 5-year follow-up were 2.3 ± 0.1 for attempted GTR, 2.9 ± 0.2 for planned subtotal removal plus radiotherapy, 3.9 ± 0.2 for biopsy plus radiotherapy, and 3.7 ± 0.2 for endoscopic resection (F = 17,150, p < 0.001). Similarly, QALYs at 10-year follow-up were 4.5 ± 0.2 for attempted GTR, 5.7 ± 0.5 for planned subtotal removal plus radiotherapy, and 7.8 ± 0.5 for biopsy plus radiotherapy (F = 6,173, p < 0.001). On post hoc pairwise comparisons, the differences between all pairs compared were also highly significant (p < 0.001). Since follow-up data at 10 years are lacking for endoscopic cases, this category was excluded from 10-year comparisons.

Conclusions: Biopsy with subsequent radiotherapy is the preferred approach with respect to improved overall quality of life. While endoscopic approaches also show promise in preserving quality of life at five-year follow-up, there are not sufficient data to draw conclusions about this comparison at 10 years.

Publication types

  • Comparative Study
  • Meta-Analysis
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Biopsy*
  • Child
  • Child, Preschool
  • Craniopharyngioma / pathology
  • Craniopharyngioma / radiotherapy*
  • Decision Support Techniques*
  • Decision Trees*
  • Female
  • Humans
  • Incidence
  • Male
  • Pituitary Neoplasms / pathology
  • Pituitary Neoplasms / radiotherapy*
  • Quality of Life*
  • Quality-Adjusted Life Years*
  • Risk
  • Treatment Outcome